To this end, we assessed the expression of Oct4, and Nanog in leptin-treated breast cancer cells and found that the expression of pluripotency genes was higher in leptin-treated cells (Figure 2B–2D) with respect to the expression in untreated cells. The gene discussed is LEP; the disease is breast cancer.